SCHEMBL23911443

SCHEMBL23911443

CC(C)(C)OC(=O)N1CCC(=O)C(C(=O)[C@H]2CCc3cc(Cl)cc(Br)c3O2)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 4/20 0.36
ESR2 Q92731 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
FNTA P49354 4/20 0.35
FNTB P49356 4/20 0.35
BRD4 O60885 1/20 0.33
CREBBP Q92793 1/20 0.33
NR1H2 P55055 1/20 0.33
MMP13 P45452 1/20 0.33
ADAM17 P78536 1/20 0.33
ADAMTS5 Q9UNA0 1/20 0.33
PARP1 P09874 1/20 0.33
PARP2 Q9UGN5 1/20 0.33
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
USP30 Q70CQ3 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911627 1.00 STS (0.36) STSESR2KDM4EMAPTTHRB
SCHEMBL23911117 0.93 ESR2 (0.37) STSESR2KDM4EMAPTTHRB
SCHEMBL23911493 0.93 ESR2 (0.37) STSESR2KDM4EMAPTTHRB
SCHEMBL23921842 0.83 FNTA (0.42) STSESR2KDM4EMAPTTHRB
SCHEMBL23921728 0.81 ESR2 (0.35) STSESR2KDM4EMAPTTHRB
SCHEMBL23910941 0.81 ESR2 (0.35) STSESR2KDM4EMAPTTHRB
SCHEMBL23910940 0.81 ESR2 (0.35) STSESR2KDM4EMAPTTHRB
SCHEMBL23911416 0.80 STS (0.39) STSESR2KDM4EMAPTTHRB
SCHEMBL23910885 0.77 STS (0.48) STSKDM4EMAPTTHRBFNTA
SCHEMBL23921707 0.76 USP7 (0.41) STSKDM4EMAPTTHRBFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF RAPT THERAPEUTICS INC (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF USP7, SENP7, USP8 STS 2095/4885ESR2 1244/4885KDM4E 1989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.